Products

Article

A round-up of the latest ophthalmic products

Objective screening

The SCORE software algorithm was developed by Drs Damien Gatinel and Alain Saad (Rothschild Foundation, Paris, France), who had compared data for corneas with no risk of ectasia against data for a group of early subclinical keratoconus eyes with significant keratoconus in the contralateral eye. This algorithm is designed to use data from the ORBSCAN IIz topographer. When examining a patient once using the topographer the software automatically associates the placido-based keratometric map, anterior and posterior corneal elevation and corneal thickness profile into one single value or SCORE.

Visit http://www.technolaspv.com/ for more information.

Laser for posterior ­segment

This laser operates at 532 nm and provides a maximum output power of 1500 mW. According to the company, its coagulation performance results in a homogeneous, sharp-edged coagulation spot.

It is available as a standalone system of can be fully integrated into the GUI of the megaTRON S4HPS with up to 12.000 cpm in vitrectomy mode. When combined, an optimized touch screen for parameterization is offered. Additionally, a new footswitch allows the user to control both devices.

Furthermore, a wide range of single-use laser probes in 20, 23 or 25 G are available from the Uno Colorline product line and curved laser probes suitable for trocar-supported PPV are also available.

Further details can be found on the company's website http://www.geuder.de/

Portable exam tool

The company states that the tool helps practitioners screen, diagnose and document ocular characteristics for contact lens fitting and general diagnostic purposes, through its ability to perform key measurements, such as pupil diameter, margin reflex distance and strabismus angle.

Additionally, it features an intuitive user interface that is reportedly easy to navigate by physicians and support staff, allowing for easy integration into practices. The real-time, accurate and objective results enable quick decisions to be made and can be output to electronic records management systems over WiFi.

Furthermore, the device can assist in the rapid identification of patients that are candidates for speciality lenses and, the company claims, reduce practice drop out rates.

More information is available on the company's website http://www.volk.com/

Collaborative technologies

This partnership, combining optical and digital microscopy into one platform, is aimed at driving precise patients outcomes, enhancing surgeon ergonomics and facilitating OR staff communication.

Dr Heinrich Dreyer, vice president of Leica Microsystems, Medical Division, said, "The partnership leverages Leica Microsystems' 'open architecture' and world-class optical, ergonomic microscopes and TrueVision's cutting edge visualization platform and suite of software applications. This integration creates a seamless, upgradeable platform that will help surgeons gain a more realistic perception of anatomical structures as a result of the depth perceived in 3D."

More details can be found by visiting http://www.leica-microsystems.com/

Recent Videos
Thomas Aaberg, MD, gives an update on Neurotech Pharmaceuticals NT-501 device for the potential treatment of retinitis pigmentosa and age-related macular degeneration, including a projected PDUFA date from the FDA at the annual ASRS meeting in Stockholm, Sweden.
Sruthi Arepalli, MD, spoke with Modern Retina about her presentation, "Assessing retinal vascular changes in alzheimer disease with radiomics: A preliminary study of fundus photography" at the annual ASRS meeting in Stockholm, Sweden.
Nathan Steinle, MD, spoke with Modern Retina about the ongoing research on the durability of sozinibercept in combination therapy with anti-VEGF-A treatments at the annual ASRS meeting in Stockholm, Sweden.
Deepak Sambhara, MD, shared an overview of his paper-on-demand, which covered real-world safety and efficacy of aflibercept, 8 mg in the treatment of neovascular age-related macular degeneration at the annual ASRS meeting in Stockholm, Sweden.
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
© 2024 MJH Life Sciences

All rights reserved.